Would you like to receive more jobs like this via email?
If you'd like, Academic Keys can email you similar job openings. You can unsubscribe at any time.
|
|
Don't want to subscribe? That's OK too!
|
Would you like to receive more jobs like this via email?
Search for University Jobs in Health Sciences
Job ID:
209129
Post-Doc Fellowship in Development of New Anti-Inflammatory and Analgesic Drug at the Center for Res
FMRP - USP
|
Date Posted
|
Apr. 17, 2023
|
Title
|
Post-Doc Fellowship in Development of New Anti-Inflammatory and Analgesic Drug at the Center for Res |
University
|
FMRP - USP
Ribeirão Preto, São Paulo, Brazil
|
Department
|
Biochemistry and Immunology |
Application Deadline
|
May 10, 2023 |
Position Start Date
|
Available immediately |
|
The Center of Research on Inflammatory Diseases – CRID, located at University of São Paulo in Ribeirão Preto, Brazil, is taking applications for a postdoctoral research position to join a project financed by FAPESP with collaboration of Brazilian National Bioscience Laboratory from the National Center of Energy and Materials (Campinas, SP). The highly motivated candidate should have taken his/her Ph.D. degree within the past 4 years in one of the following areas: Pharmacology, Biochemistry, Molecular and Cellular Biology, Immunology, and areas related to drug discovery or similar fields. The candidate must have experience in cell culture techniques, biochemical and molecular assays, as well as in vivo models of inflammation and/or pain.Excellent oral and written communication skills are required. Please submit your complete application by 05/10/2023 (cover letter, CV and 2 recommendation letters) to Thiago Mattar Cunha (crid@fmrp.usp.br)
Research Inflammatory diseases constitute a complex and heterogeneous group of diseases, being an important cause of morbidity and mortality. In this project, we intend to develop translational research in the field of Inflammatory Diseases. In addition, the association with chemists with training in molecular modeling and synthesis of molecules will allow the development of new drugs for the treatment of diseases, such as: 1) chronic neuropathic pain; 2) autoimmune inflammatory diseases (rheumatoid arthritis, psoriasis) 3) Infectious (Sepsis, COVID-19) The development of the project will allow the development of new molecules that modulate the activity of biological targets involved in the aforementioned inflammatory diseases. For this, in vitro and in vivo studies will be carried out with molecules already identified in screening tests.
|
Please reference AcademicKeys.com in your cover letter when
applying for or inquiring about this job announcement.
Contact Information
|
|
Refer this job to a friend or colleague!
|
|
New Search |
Previous
|
|
|